AbbVie Inc. (ABBV) will begin trading ex-dividend on October 14, 2021. A cash dividend payment of $1.3 per share is scheduled to be paid on November 15, 2021. Shareholders who purchased ABBV prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 4th quarter that ABBV has paid the same dividend. At the current stock price of $108.57, the dividend yield is 4.79%.
The previous trading day's last sale of ABBV was $108.57, representing a -10.66% decrease from the 52 week high of $121.53 and a 37.24% increase over the 52 week low of $79.11.
ABBV is a part of the Health Care sector, which includes companies such as McKesson Corporation (MCK) and AmerisourceBergen Corporation (Holding Co) (ABC). ABBV's current earnings per share, an indicator of a company's profitability, is $3.71. Zacks Investment Research reports ABBV's forecasted earnings growth in 2021 as 19.79%, compared to an industry average of 3.6%.
Interested in gaining exposure to ABBV through an Exchange Traded Fund [ETF]?
The following ETF(s) have ABBV as a top-10 holding:
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
- First Trust Morningstar ETF (FDL)
- Invesco Dynamic Pharmaceuticals ETF (PJP)
- iShares Evolved U.S. Innovative Healthcare ETF (IEIH)
- WisdomTree U.S. High Dividend Fund (DHS).
The top-performing ETF of this group is IEIH with an increase of 2.26% over the last 100 days. FTXH has the highest percent weighting of ABBV at 7.32%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.